速碧林对不稳定型心绞痛作用的临床研究

Clinical Observation on Unstable Angina Treated Fraxiparine

目的：观察速碧林治疗不稳定型心绞痛（UAP）的临床疗效。方法：将238例UAP患者随机分为常规治疗组（对照组）及常规治疗加速碧林组（观察组），疗程为1周。结果：1周后总有效率观察组为97％，对照组为70％（P〈0．05）；观察12周，观察组无一例发生急性心肌梗死（AMI），对照组9例发生AMI（7.8％）；观察组未发现明显副作用。结论：在常规治疗基础上加用速碧林，能更有效的控制心绞痛发作，减少AMI的发生率。

Objective Observe the clinical curative effect of fraxiparine in treatment of unstable angina （UAP）. Methods Will 238 regular UAP patients radom divide into conventional observation group （compare group） and conventional treatment add fraxiparine group （observation group） , course of treatment is one week. Results 1 weeks later, it is 97% to observe group always efficently, comparing with group, is 70% （P 〈0.05） ; Observe for 12 weeks, observe group do not have a example occur acute myocardial infarction, comparing with 9 group examples, occur myocardial infarction （7.8%） ; Observe group do not discover obvious side effect. Gonclusioa On conventional treatment foundation, add to use fraxiparine, can be more effective to control angina to break out, reduce the occurence rate with dead AMI.